Evaluation of memory deficit


Key articles

Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126-35.Full text  Abstract

National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].Full text

Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.Full text  Abstract

Reference articles

1. Dillon DG, Pizzagalli DA. Mechanisms of memory disruption in depression. Trends Neurosci. 2018 Mar;41(3):137-49.Full text  Abstract

2. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22.Full text  Abstract

3. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29.Full text  Abstract

4. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 4;89(1):88-100.Full text  Abstract

5. Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003 Jul 8;61(1):40-5. Abstract

6. St Louis EK, Boeve AR, Boeve BF. REM sleep behavior disorder in Parkinson's disease and other synucleinopathies. Mov Disord. 2017 May;32(5):645-58. Abstract

7. Lee SE, Rabinovici GD, Mayo MC, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011 Aug;70(2):327-40.Full text  Abstract

8. Paterson RW, Torres-Chae CC, Kuo AL, et al. Differential diagnosis of jakob-creutzfeldt disease. Arch Neurol. 2012 Dec;69(12):1578-82.Full text  Abstract

9. Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep. 2008 Sep;8(5):371-6.Full text  Abstract

10. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939-44. Abstract

11. Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126-35.Full text  Abstract

12. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 Mar;56(3):303-8.Full text  Abstract

13. Barnes DE, Whitmer RA, Yaffe K. Physical activity and dementia: the need for prevention trials. Exerc Sport Sci Rev. 2007 Jan;35(1):24-9. Abstract

14. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30;69(18):1789-99.Full text  Abstract

15. O'Byrne P, MacPherson P. Syphilis. BMJ. 2019 Jun 28;365:l4159. [Erratum in: BMJ. 2019 Jul 19;366:l4746.]Full text  Abstract

16. McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013 Jan;136(Pt 1):43-64.Full text  Abstract

17. Giza CC, Kutcher JS, Ashwal S, et al. Summary of evidence-based guideline update: evaluation and management of concussion in sports: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 Jun 11;80(24):2250-7.Full text  Abstract

18. McKee AC, Daneshvar DH, Alvarez VE, et al. The neuropathology of sport. Acta Neuropathol. 2014 Jan;127(1):29-51.Full text  Abstract

19. Nordström A, Nordström P. Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study. PLoS Med. 2018 Jan 30;15(1):e1002496.Full text  Abstract

20. Lim C, Alexander MP, LaFleche G, et al. The neurological and cognitive sequelae of cardiac arrest. Neurology. 2004 Nov 23;63(10):1774-8. Abstract

21. Leritz EC, Grande LJ, Bauer RM. Temporal lobe epilepsy as a model to understand human memory: the distinction between explicit and implicit memory. Epilepsy Behav. 2006 Aug;9(1):1-13. Abstract

22. Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol. 2009 Mar-Apr;44(2):155-65.Full text  Abstract

23. Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):51-60.Full text  Abstract

24. Stojsavljevic N, Levic Z, Drulovic J, et al. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology. 1997 Sep;49(3):878-81. Abstract

25. Kuljic-Obradovic D, Labudovic G, Basurovic N, et al. Neuropsychological deficits after bithalamic hemorrhages. J Neurol Sci. 2007 Jun 15;257(1-2):174-6. Abstract

26. Karussis D, Leker RR, Abramsky O. Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature. J Neurol Sci. 2000 Jan 1;172(1):25-9. Abstract

27. Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418. [Erratum in: Stroke. 2019 Dec;50(12):e440-1.]Full text  Abstract

28. National Institute for Health and Care Excellence (UK). Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. Apr 2022 [internet publication].Full text

29. Expert Panel on Neurologic Imaging, Salmela MB, Mortazavi S, et al. ACR Appropriateness Criteria® cerebrovascular disease. J Am Coll Radiol. 2017 May;14(5s):S34-61.Full text  Abstract

30. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48-61.Full text  Abstract

31. Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist. 2005 Nov;11(6):348-61. Abstract

32. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003 Feb;60(2):164-71.Full text  Abstract

33. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb;63(2):197-202.Full text  Abstract

34. Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. Neurologist. 2007 May;13(3):140-7. Abstract

35. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63-74.Full text  Abstract

36. McKeon A, Lennon VA, Pittock SJ. Immunotherapy-responsive dementias and encephalopathies. Continuum (Minneap Minn). 2010 Apr;16(2 Dementia):80-101. Abstract

37. Rosenfeld MR, Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol. 2011 Jun;13(3):324-32.Full text  Abstract

38. Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):51-60.Full text  Abstract

39. Cirignotta F, Manconi M, Mondini S, et al. Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity: report of a case. Arch Neurol. 2000 Sep;57(9):1356-9. Abstract

40. Karlawish JH, Clark CM. Diagnostic evaluation of elderly patients with mild memory problems. Ann Intern Med. 2003 Mar 4;138(5):411-9. Abstract

41. Kalisch Ellett LM, Pratt NL, Ramsay EN, et al. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J Am Geriatr Soc. 2014 Oct;62(10):1916-22. Abstract

42. Snowdon J. Pseudodementia, a term for its time: the impact of Leslie Kiloh's 1961 paper. Australas Psychiatry. 2011 Oct;19(5):391-7. Abstract

43. Kennedy J. Depressive pseudodementia - how ‘pseudo’ is it really? Old Age Psychiatrist. 2015;62:1-7.Full text

44. Budson AE, Price BH. Memory dysfunction. N Engl J Med. 2005 Feb 17;352(7):692-9. Abstract

45. O'Brien JT, Thomas A. Vascular dementia. Lancet. 2015 Oct 24;386(10004):1698-706. Abstract

46. Abell JG, Kivimäki M, Dugravot A, et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018 Sep 1;39(33):3119-25.Full text  Abstract

47. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011 Jun;13(6):597-605.Full text  Abstract

48. Kovács GG, Puopolo M, Ladogana A, et al; EUROCJD. Genetic prion disease: the EUROCJD experience Hum Genet. 2005 Nov;118(2):166-74. Abstract

49. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].Full text

50. National Institute for Health and Care Excellence (UK). British National Formulary. 2021 [internet publication].Full text

51. Samaras K, Makkar SR, Crawford JD, et al. Effects of statins on memory, cognition, and brain volume in the elderly. J Am Coll Cardiol. 2019 Nov 26;74(21):2554-68.Full text  Abstract

52. Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.Full text  Abstract

53. Driver and Vehicle Licensing Agency. Assessing fitness to drive: a guide for medical professionals. 3 August 2018 [internet publication].Full text

54. Quinn TJ, Fearon P, Noel-Storr AH, et al. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations. Cochrane Database Syst Rev. 2021 Jul 19;7:CD010079.Full text  Abstract

55. Harrison JK, Fearon P, Noel-Storr AH, et al. Informant questionnaire on cognitive decline in the elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev. 2015 Mar 10;(3):CD010772.Full text  Abstract

56. Zeng L, Josephson SA, Fukuda KA, et al. A prospective comparison of informant-based and performance-based dementia screening tools to predict in-hospital delirium. Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):312-6.Full text  Abstract

57. Holsinger T, Deveau J, Boustani M, et al. Does this patient have dementia? JAMA. 2007 Jun 6;297(21):2391-404. Abstract

58. Krueger CE, Kramer JH. Neurocognitive assessment. Continuum (Minneap Minn). 2010 Apr;16(2 Dementia):176-90. Abstract

59. Haubois G, de Decker L, Annweiler C, et al. Derivation and validation of a short form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint. Eur J Neurol. 2013 Mar;20(3):588-90. Abstract

60. Haubois G, Annweiler C, Launay C, et al. Development of a short form of Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint: a case control study. BMC Geriatr. 2011 Oct 4;11:59.Full text  Abstract

61. Schroeder RW, Twumasi-Ankrah P, Baade LE, Marshall PS. Reliable Digit Span: a systematic review and cross-validation study. Assessment. 2012 Mar;19(1):21-30. Abstract

62. Jackson TA, Naqvi SH, Sheehan B. Screening for dementia in general hospital inpatients: a systematic review and meta-analysis of available instruments. Age Ageing. 2013 Nov;42(6):689-95.Full text  Abstract

63. Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005 Sep 2;19(13):1367-74.Full text  Abstract

64. Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145.Full text  Abstract

65. Ranson JM, Kuźma E, Hamilton W, et al. Predictors of dementia misclassification when using brief cognitive assessments. Neurol Clin Pract. 2019 Apr;9(2):109-17.Full text  Abstract

66. Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8. Abstract

67. Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Cochrane Database Syst Rev. 2018 Feb 22;(2):CD011415.Full text  Abstract

68. Derby CA, Burns LC, Wang C, et al. Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology. 2013 Apr 2;80(14):1307-14.Full text  Abstract

69. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review) - report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1143-53. Abstract

70. Vitali P, Migliaccio R, Agosta F, et al. Neuroimaging in dementia. Semin Neurol. 2008 Sep;28(4):467-83.Full text  Abstract

71. Shetty VS, Reis MN, Aulino JM, et al. ACR Appropriateness Criteria head trauma. J Am Coll Radiol. 2016 Jun;13(6):668-79. Abstract

72. Goto H, Ishii K, Uemura T, et al. Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol. 2010 Apr;31(4):720-5.Full text  Abstract

73. Oudshoorn C, Mattace-Raso FU, van der Velde N, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25(6):539-43. Abstract

74. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010 Jul 12;170(13):1135-41.Full text  Abstract

75. Annweiler C, Schott AM, Berrut G, et al. Vitamin D and ageing: neurological issues. Neuropsychobiology. 2010 Aug;62(3):139-50.Full text  Abstract

76. Irani SR, Vincent A. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Arq Neuropsiquiatr. 2012 Apr;70(4):300-4.Full text  Abstract

77. Rosenbloom MH, Smith S, Akdal G, Geschwind MD. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.Full text  Abstract

78. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011 Oct 20;72(2):245-56.Full text  Abstract

79. Liu Y, Yu JT, Zong Y, et al. C9ORF72 mutations in neurodegenerative diseases. Mol Neurobiol. 2014 Feb;49(1):386-98. Abstract

80. Cooper-Knock J, Shaw PJ, Kirby J. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol. 2014 Mar;127(3):333-45.Full text  Abstract

81. Devenney E, Hornberger M, Irish M, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014 Mar;71(3):331-9. Abstract

82. Gijselinck I, Van Langenhove T, van der Zee J, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012 Jan;11(1):54-65. Abstract

83. Donnelly CJ, Zhang PW, Pham JT, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013 Oct 16;80(2):415-28.Full text  Abstract

84. Gendron TF, Bieniek KF, Zhang YJ, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013 Dec;126(6):829-44.Full text  Abstract

85. Mori K, Weng SM, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013 Mar 15;339(6125):1335-8. Abstract

86. MacLeod R, Tibben A, Frontali M, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013 Mar;83(3):221-31.Full text  Abstract

87. Ritchie C, Smailagic N, Noel-Storr AH, et al. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017 Mar 22;(3):CD010803.Full text  Abstract

88. Williams MA, Thomas G, de Lateur B, et al. Objective assessment of gait in normal-pressure hydrocephalus. Am J Phys Med Rehabil. 2008 Jan;87(1):39-45. Abstract

89. Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):503-6.Full text  Abstract

90. Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4703-7.Full text  Abstract

91. Knopman DS. Cerebrovascular disease and dementia. Br J Radiol. 2007 Dec;80 Spec No 2:S121-7. Abstract

92. Metzler-Baddeley C. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia. Cortex. 2007 Jul;43(5):583-600. Abstract

93. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13;68(11):812-9. Abstract

94. Feinberg TE, Farah MJ, eds. Behavioral neurology and neuropsychology. New York, NY: McGraw-Hill; 1997.

95. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003 Apr 8;60(7):1094-7. Abstract

96. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546-54. Abstract

97. Miller BL, Gearhart R. Neuroimaging in the diagnosis of frontotemporal dementia. Dement Geriatr Cogn Disord. 1999;10(suppl 1):71-4. Abstract

98. Seeley WW, Bauer AM, Miller BL, et al. The natural history of temporal variant frontotemporal dementia. Neurology. 2005 Apr 26;64(8):1384-90.Full text  Abstract

99. Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. Abstract

100. Goldman JS, Miller BL, Safar J, et al. When sporadic disease is not sporadic: the potential for genetic etiology. Arch Neurol. 2004 Feb;61(2):213-6.Full text  Abstract

101. Fogel B, Wu M, Kremen S, et al. Creutzfeldt-Jakob disease presenting with alien limb sign. Mov Disord. 2006 Jul;21(7):1040-2. Abstract

102. Carswell C, Thompson A, Lukic A, et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol. 2012 Dec 5;12:153.Full text  Abstract

103. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May 17;76(20):1711-9.Full text  Abstract

104. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62.Full text  Abstract

105. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006 Sep;129(Pt 9):2278-87.Full text  Abstract

106. Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004 Nov;56(5):702-8. Abstract

107. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003 Jun;60(6):813-6.Full text  Abstract

108. Hamlin C, Puoti G, Berri S, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012 Aug 7;79(6):547-52.Full text  Abstract

109. Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008 Mar;14(2):100-7. Abstract

110. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1974 Feb;37(2):121-30.Full text  Abstract

111. Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999 Sep;246(suppl 2):II1-5. Abstract

112. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964 Apr;10:333-59. Abstract

113. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997 Jan;120 (Pt 1):65-74.Full text  Abstract

114. Esmonde T, Giles E, Gibson M, et al. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol. 1996 Sep;243(9):638-43. Abstract

115. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006 Jan;63(1):81-6.Full text  Abstract

116. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54(suppl 5):S15-9. Abstract

117. Sha S, Hou C, Viskontas IV, et al. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? Nat Clin Pract Neurol. 2006 Dec;2(12):658-65. Abstract

118. Tree JJ, Kay J. Longitudinal assessment of language and memory impairments in pathologically confirmed cortico-basal ganglionic degeneration. Cortex. 2008 Oct;44(9):1234-47. Abstract

119. Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005 Sep;57(3 suppl):S4-16. Abstract

120. Qureshi AI, Williams MA, Razumovsky AY, et al. Magnetic resonance imaging, unstable intracranial pressure and clinical outcome in patients with normal pressure hydrocephalus. Acta Neurochir Suppl. 1998;71:354-6. Abstract

121. Virhammar J, Cesarini KG, Laurell K. The CSF tap test in normal pressure hydrocephalus: evaluation time, reliability and the influence of pain. Eur J Neurol. 2012 Feb;19(2):271-6. Abstract

122. Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007 Jun;13(3):203-9. Abstract

123. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005 Sep;4(9):543-55. Abstract

124. US Centers for Disease Control and Prevention. Laboratory testing for the diagnosis of HIV infection: updated recommendations. 27 June 2014 [internet publication].Full text

125. Grossman RI , Yousem DM, eds. Neuroradiology: the requisites. 2nd ed. Philadelphia, PA: Mosby; 2003.

126. Adams RD, Victor M, Ropper AH. Principles of neurology. 6th ed. New York, NY: McGraw-Hill; 1997:877.

127. Kingston M, French P, Higgins S, et al; British Association for Sexual Health and HIV. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016 May;27(6):421-46.Full text  Abstract

128. Pope V, Fears MB, Morrill WE, et al. Comparison of the Serodia Treponema pallidum particle agglutination, Captia Syphilis-G, and SpiroTek Reagin II tests with standard test techniques for diagnosis of syphilis. J Clin Microbiol. 2000 Jul;38(7):2543-5.Full text  Abstract

129. Rosenbloom MH, Smith S, Akdal G, et al. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.Full text  Abstract

130. Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006 Jun;33(3):270-98. Abstract

131. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008 Oct;65(10):1341-6.Full text  Abstract

132. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 Mar;127(Pt 3):701-12.Full text  Abstract

133. Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002 May;51(5):625-30. Abstract

134. Ropper AH, Gorson KC. Clinical practice: concussion. N Engl J Med. 2007 Jan 11;356(2):166-72. Abstract

135. Guo Z, Cupples LA, Kurz A, et al. Head injury and the risk of AD in the MIRAGE study. Neurology. 2000 Mar 28;54(6):1316-23. Abstract

136. Orrison WW, Hanson EH, Alamo T, et al. Traumatic brain injury: a review and high-field MRI findings in 100 unarmed combatants using a literature-based checklist approach. J Neurotrauma. 2009 May;26(5):689-701. Abstract

137. McCrory P, Zazryn T, Cameron P. The evidence for chronic traumatic encephalopathy in boxing. Sports Med. 2007;37(6):467-76. Abstract

138. Handratta V, Hsu E, Vento J, et al. Neuroimaging findings and brain-behavioral correlates in a former boxer with chronic traumatic brain injury. Neurocase. 2010 Apr;16(2):125-34. Abstract

139. Samuels MA, Feske S, eds. Office practice of neurology. 2nd ed. New York, NY: Churchill Livingstone; 2003.

140. Bradley W, Daroff RB, Fenichel G, et al, eds. Neurology in clinical practice. 4th ed. Philadelphia, PA: Butterworth Heinemann; 2004.

141. Carrera E, Bogousslavsky J. The thalamus and behavior: effects of anatomically distinct strokes. Neurology. 2006 Jun 27;66(12):1817-23. Abstract

142. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70. Abstract

143. Sander K, Sander D. New insights into transient global amnesia: recent imaging and clinical findings. Lancet Neurol. 2005 Jul;4(7):437-44. Abstract

144. Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006 Jul;129(Pt 7):1640-58.Full text  Abstract

145. Halavaara J, Brander A, Lyytinen J, et al. Wernicke's encephalopathy: is diffusion-weighted MRI useful? Neuroradiology. 2003 Aug;45(8):519-23. Abstract

146. Peterson RC. Mild cognitive impairment. Continuum Lifelong Learning Neurol. 2007;13:15-38.

147. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999 Apr 22;52(7):1397-403.Full text  Abstract

148. Aggarwal NT, Wilson RS, Beck TL, et al. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb;11(1):3-7. Abstract

149. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995 Apr 26;273(16):1274-8. Abstract

Use of this content is subject to our disclaimer